Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/99357
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.creatorZhang, JLen_US
dc.creatorDu, Cen_US
dc.creatorPoon, CCWen_US
dc.creatorHe, MCen_US
dc.creatorWong, MSen_US
dc.creatorWang, NNen_US
dc.creatorZhang, Yen_US
dc.date.accessioned2023-07-07T08:28:42Z-
dc.date.available2023-07-07T08:28:42Z-
dc.identifier.issn0378-8741en_US
dc.identifier.urihttp://hdl.handle.net/10397/99357-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rights© 2022 Elsevier B.V. All rights reserved.en_US
dc.rights© 2022. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.en_US
dc.rightsThe following publication Zhang, J.-L., Du, C., Poon, C. C.-W., He, M.-C., Wong, M.-S., Wang, N.-N., & Zhang, Y. (2023). Structural characterization and protective effect against renal fibrosis of polysaccharide from Ligustrum lucidum Ait. Journal of Ethnopharmacology, 302, 115898 is available at https://dx.doi.org/10.1016/j.jep.2022.115898.en_US
dc.subjectAngiotensin IIen_US
dc.subjectFibrosisen_US
dc.subjectFructus Ligustri Lucidien_US
dc.subjectKidneyen_US
dc.subjectPolysaccharideen_US
dc.titleStructural characterization and protective effect against renal fibrosis of polysaccharide from Ligustrum lucidum Ait.en_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume302en_US
dc.identifier.doi10.1016/j.jep.2022.115898en_US
dcterms.abstractEthnopharmacological relevance: Fructus Ligustri Lucidi (FLL), the fruit of Ligustrum lucidum Ait., is a traditional Chinese medicine that has been used for tonifying the kidney and liver for decades.en_US
dcterms.abstractAim of the study: This study aimed to explore and identify polysaccharides from FLL and elucidate its protective effect against renal fibrosis.en_US
dcterms.abstractMaterials and methods: Polysaccharides were extracted and isolated from FLL. The purified fraction was identified by serial phytochemical work, such as gel-permeation chromatography, ion chromatography, gas chromatography-mass spectrometry, and nuclear magnetic resonance. Mice with unilateral ureteral obstruction (UUO) were applied as a renal fibrosis model. The male UUO mice were pretreated with heteropolysaccharide (Poly) 1 week prior to surgery and continuously treated for 7 days after the operation. Renal fibrosis was assessed by Periodic Acid-Schiff (PAS) staining and Masson's trichrome staining in paraffin-embedded slides. The murine mesangial cells SV40-MES13 upon angiotensin II (Ang II) treatment were developed as an in vitro fibrotic model. The cells were treated by Poly in the presence of Ang II. Molecular expression was detected by RT-PCR, immunoblotting, and immunofluorescence staining. Results: We identified a heteropolysaccharide composed of arabinose and galactose (molar ratio, 0.73:0.27) with a predicted chemical structure characterized by a backbone composed of 1,5-α-Araf, 1,3,5-α-Araf, 1,6-α-Galp, and 1,3,6-β-Galp and side chains comprised of T-α-Araf, T-α-Arap, and 1,3-α-Araf. Pretreatment of UUO mice with Poly effectively alleviated glomerulosclerosis and tubulointerstitial fibrosis. Moreover, Poly pretreatment down-regulated the expression of extracellular matrix (ECM) protein fibronectin (FN), profibrotic factor VEGF, proinflammatory cytokines MCP-1 and Rantes in the obstructed kidney. Similarly, the incubation of SV40-MES13 cells with Poly significantly inhibited Ang II-induced elevation in accumulation and expression level of FN and attenuated Ang II-evoked up-regulation in protein expression of MCP-1 and Rantes.en_US
dcterms.abstractConclusions: Our study isolated and identified a naturally occurring heteropolysaccharide in FLL and revealed its potential in protecting the kidneys from fibrosis.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationJournal of ethnopharmacology, 10 Feb. 2023, v. 302, part A, 115898en_US
dcterms.isPartOfJournal of ethnopharmacologyen_US
dcterms.issued2023-02-10-
dc.identifier.scopus2-s2.0-85143088639-
dc.identifier.pmid36372193-
dc.identifier.eissn1872-7573en_US
dc.identifier.artn115898en_US
dc.description.validate202307 bcwwen_US
dc.description.oaAccepted Manuscripten_US
dc.identifier.FolderNumbera2220, a2235-
dc.identifier.SubFormID47091, 47179-
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNational Natural Science foundation of China; Scientific and Innovative Action Plan from Science and Technology Commission of Shanghai Municipality ; Shanghai Collaborative Innovation Center of Industrial Transformation of Hospital TCM Preparationen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Zhang_Structural_Characterization_Protective.pdfPre-Published version1.01 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Final Accepted Manuscript
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

138
Last Week
6
Last month
Citations as of Nov 30, 2025

Downloads

96
Citations as of Nov 30, 2025

SCOPUSTM   
Citations

12
Citations as of Aug 22, 2025

WEB OF SCIENCETM
Citations

15
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.